v3.25.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 411 $ 2,392
General and administrative 1,494 1,316
Loss from operations (1,905) (3,708)
Other income (expense):    
Interest income 32 49
Loss on settlement of common stock warrant liabilities 0 (574)
Change in fair value of warrant liabilities 15 (116)
Total other income (expense) 47 (641)
Net loss (1,858) (4,349)
Net loss attributable to non-controlling interests (6) (9)
Net loss attributable to common stockholders $ (1,852) $ (4,340)
Net loss per common share attributable to common stockholders, basic and diluted (in dollars per share) $ (0.62) $ (15.4)
Weighted average number of common shares outstanding, basic and diluted (in shares) 2,970,807 562,031

Source